Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
02/2005
02/17/2005WO2005014579A1 Imidazol derivatives of piperdine as histamine antagonists
02/17/2005WO2005014555A1 4,5-dihydro-imidazole as p2x7 ion channel blockers
02/17/2005WO2005014552A1 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
02/17/2005WO2005014540A1 Cyclic amine base-1 inhibitors having a heterocyclic substituent
02/17/2005WO2005013985A1 Treatment for alzheimer's disease and related conditions
02/17/2005WO2005013979A1 Indol-7 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
02/17/2005WO2005013978A1 Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
02/17/2005WO2005013977A1 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
02/17/2005WO2005013976A1 Indol-6 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
02/17/2005WO2005013914A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
02/17/2005WO2004094386A8 Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b)
02/17/2005WO2004092115A3 Hydroxamates as therapeutic agents
02/17/2005WO2004084813A3 Chemical compounds
02/17/2005WO2004063330A3 (2-carboxamido) (3-amino) thiophene compounds
02/17/2005US20050038246 PPAR active compounds
02/17/2005US20050038243 2, 4-pyrimidinediamine compounds and their uses
02/17/2005US20050038104 Substitute benzothiophene compounds
02/17/2005US20050038101 Substituted 2 5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases
02/17/2005US20050038100 Eating disorders; anticholesterol agents; hypotensive agents; sleep disorders; hyperphagia
02/17/2005US20050038099 3-Amido-5-substituted pyrazole derivatives and related compounds useful as bradykinin B1 receptor antagonists to relieve adverse symptoms in mammals mediated, at least in part, by bradykinin B1 receptor including pain, inflammation, septic shock, scarring process
02/17/2005US20050038095 Azolylbenzamides and analogues and their use for treating osteoporosis
02/17/2005US20050038087 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
02/17/2005US20050038084 Phenylalanine enamide derivatives
02/17/2005US20050038072 Nitrogeneous cyclic ketone derivative, process for producing the same, and use
02/17/2005US20050038069 Tumor necrosis factor antagonist; antiinflammatory agents; such as 2-Cyclopropyl-4-(3,5-dimethyl-4-pyridylmethoxy)-7-methoxy-3H-benzimidazole
02/17/2005US20050038051 Novel molecules for regulating cell death
02/17/2005US20050038037 N-(naphth-2-ylaminocarbonylacetyl)- or N-(naphth-2-ylcarbonylamino- acetyl)- piperazine derivatives, e.g., 2-[((4-(ethoxycarbonyl)piperazin-1-yl)carbonylmethyl)carbonyl]aminonaphthalene; useful as antithrombotic agents
02/17/2005US20050038035 Heterocyclic amide compounds as apolipoprotein b inhibitors
02/17/2005US20050038025 Thioarabinofuranosyl compounds and use thereof
02/17/2005US20050038023 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
02/17/2005US20050038021 2,4,5,-trisubstituted phenylketo-enols for use as pesticides and herbicides
02/17/2005US20050037925 Mixture with other herbicides
02/17/2005DE10328533A1 New 6-amino-substituted indolinone derivatives, useful e.g. for treating tumours and angiogenesis, are inhibitors of receptor tyrosine kinases
02/17/2005CA2539227A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
02/17/2005CA2534240A1 Treatment for alzheimer's disease and related conditions
02/17/2005CA2534136A1 Indol-7 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
02/17/2005CA2534098A1 Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
02/17/2005CA2534057A1 Novel gamma-secretase inhibitors
02/17/2005CA2533976A1 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
02/17/2005CA2533970A1 Indol-6 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
02/17/2005CA2532910A1 4,5-dihydro-imidazole as p2x7 ion channel blockers
02/17/2005CA2532452A1 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
02/16/2005EP1506967A1 Dipeptidyl peptidase inhibitors
02/16/2005EP1506962A2 Nitrogen-containing aromatic heterocycles
02/16/2005EP1506959A2 Derivatised molecules for mass spectrometry
02/16/2005EP1506777A1 Obesity preventive or ameliorator containing methylidene hydrazide compound as active ingredient
02/16/2005EP1506190A1 (imidazol-1-yl-methyl)-pyridazine as nmda receptor blocker
02/16/2005EP1506188A1 Process for the preparation of a hydrate of an anthranilic acid derivative
02/16/2005EP1506185A1 Novel compounds and their use
02/16/2005EP1506176A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
02/16/2005EP1506174A2 Opioid and opioid-like compounds and uses thereof
02/16/2005EP1506166A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
02/16/2005EP1505966A1 1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors
02/16/2005EP1395553B1 Pyrrolidine derivatives as factor xa inhibitors
02/16/2005EP1246814B1 Compounds and methods for modulation of estrogen receptors
02/16/2005EP1244617B1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
02/16/2005CN1582287A Thiophenylthiopyrane dioxides as MMP or TNF-alpha inhibitors
02/16/2005CN1582285A Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (GSK3 inhibitors)
02/16/2005CN1582284A Aminopyrimidines and pyridines
02/16/2005CN1582283A Benzothiepine ileal bile acid transport inhibitors
02/16/2005CN1582281A Mch受体拮抗剂 Mch receptor antagonist
02/16/2005CN1582280A 3, 4-di-substituted pyridazinediones as CXC chemokine receptor antagonists
02/16/2005CN1582276A Phenylalanine enamide derivatives
02/16/2005CN1582275A Calcium antagonistic compound
02/16/2005CN1582271A Inhibitors of integrin alpha v beta 6
02/16/2005CN1189467C Pharmaceutically active sulfonamide derivatives
02/16/2005CN1189170C Thienylazolylal coxyethanamines, their preparation and their application as medicaments
02/15/2005US6855832 O- or S-substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
02/15/2005US6855730 3-methylidenyl-2-indolinone modulators of protein kinase
02/15/2005US6855726 Heterocyclic amides such as 3-(1-5-((2R,6S)-2,6-dimethyltetra-hydro-1(2H)-pyridinyl)pentyl-2-oxo-1,2 -dihydro-3-quinolinyl) benzenecarboximidamide, administered as anticoagulants or for prophylaxis of cardiovascular disorders
02/15/2005US6855715 Drugs such as 1-(3-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4-(4-fluoro-2 -methylsulphonylphenyl)piperazine, used as anticoagulants
02/15/2005US6855714 For therapy of inflammatory, allergic, infectious or autoimmune diseases
02/15/2005US6855713 Benzimidazole derivatives, a process for their manufacture and use as a medicine
02/15/2005US6855512 Phenylacetic or heteroarylacetic acid derivatives; retinoid like activity
02/15/2005CA2107223C Crystalline tiagabine hydrochloride monohydrate, its preparation and use
02/10/2005WO2005012291A1 3-amino choman and 2-amino tetralin derivatives
02/10/2005WO2005012288A1 Bicyclic imidazol derivatives against flaviviridae
02/10/2005WO2005012283A1 Substituted benzothiophene compounds and uses thereof
02/10/2005WO2005012280A1 Alkynyl aryl carboxamides
02/10/2005WO2005012263A1 5-ht2b receptor antagonists
02/10/2005WO2005012256A1 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
02/10/2005WO2005011700A1 INHIBITORS OF Akt ACTIVITY
02/10/2005WO2005011657A2 Piperazine derivatives and their use as therapeutic agents
02/10/2005WO2005011646A2 Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-ii receptor blockers for the treatment of cardiovascular diseases
02/10/2005WO2004103976A3 Method for synthesising heterocyclic compounds from thiourea derivatives
02/10/2005WO2004099191A3 Benzofuranyl-and benzothienyl-piperazinyl quinolines as serotonin reuptake inhib itors
02/10/2005WO2004093856A3 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
02/10/2005US20050033057 Thiazoline acid derivatives
02/10/2005US20050033055 Edg receptor agonists
02/10/2005US20050032881 Novel non-psychotropic cannabinoids
02/10/2005US20050032873 3-Amino chroman and 2-amino tetralin derivatives
02/10/2005US20050032860 CBI analogs of CC-1065 and the duocarmycins
02/10/2005US20050032809 5-HT receptor ligands and uses thereof
02/10/2005US20050032805 Antimicrobial biaryl compounds
02/10/2005US20050032791 Derivatives of sulphonamides, their preparation and use as medicaments
02/10/2005US20050032746 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
02/10/2005US20050030912 Use of hybrid (HW/DSP/MCU/SW) architectures for powerline OFDM communication field
02/10/2005CA2534649A1 Bicyclic imidazol derivatives against flaviviridae
02/10/2005CA2534451A1 Angiotensin ii receptor blocker derivatives
02/10/2005CA2534127A1 Substituted benzothiophene compounds and uses thereof